Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Brain metastases: neuroimaging
WB Pope - Handbook of clinical neurology, 2018 - Elsevier
Magnetic resonance imaging (MRI) is the cornerstone for evaluating patients with brain
masses such as primary and metastatic tumors. Important challenges in effectively detecting …
masses such as primary and metastatic tumors. Important challenges in effectively detecting …
PET imaging in patients with brain metastasis—report of the RANO/PET group
Brain metastases (BM) from extracranial cancer are associated with significant morbidity and
mortality. Effective local treatment options are stereotactic radiotherapy, including …
mortality. Effective local treatment options are stereotactic radiotherapy, including …
Combining amino acid PET and MRI imaging increases accuracy to define malignant areas in adult glioma
M Harat, J Rakowska, M Harat, T Szylberg… - Nature …, 2023 - nature.com
Accurate determination of the extent and grade of adult-type diffuse gliomas is critical to
patient management. In clinical practice, contrast-enhancing areas of diffuse gliomas in …
patient management. In clinical practice, contrast-enhancing areas of diffuse gliomas in …
PET imaging in patients with meningioma—report of the RANO/PET Group
Meningiomas are the most frequent nonglial primary brain tumors and represent about 30%
of brain tumors. Usually, diagnosis and treatment planning are based on neuroimaging …
of brain tumors. Usually, diagnosis and treatment planning are based on neuroimaging …
Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: response, progression, and pseudoprogression
The advent of immunotherapy using immune checkpoint inhibitors (ICIs) and targeted
therapy (TT) has dramatically improved the prognosis of various cancer types. However …
therapy (TT) has dramatically improved the prognosis of various cancer types. However …
Imaging glioblastoma posttreatment: progression, pseudoprogression, pseudoresponse, radiation necrosis
SB Strauss, A Meng, EJ Ebani… - Neuroimaging …, 2021 - neuroimaging.theclinics.com
Eighty percent of all malignant primary brain tumors diagnosed in the United States are
gliomas. 1 The current treatment paradigm for high-grade gliomas (grades III and IV) …
gliomas. 1 The current treatment paradigm for high-grade gliomas (grades III and IV) …
Current status of PET imaging in neuro-oncology
Over the past decades, a variety of PET tracers have been used for the evaluation of patients
with brain tumors. For clinical routine, the most important clinical indications for PET imaging …
with brain tumors. For clinical routine, the most important clinical indications for PET imaging …
Distinguishing true progression from radionecrosis after stereotactic radiation therapy for brain metastases with machine learning and radiomics
Purpose Treatment effect or radiation necrosis after stereotactic radiosurgery (SRS) for brain
metastases is a common phenomenon often indistinguishable from true progression …
metastases is a common phenomenon often indistinguishable from true progression …
Recent developments and future directions in adult lower-grade gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) …
D Schiff, M Van den Bent, MA Vogelbaum… - Neuro …, 2019 - academic.oup.com
The finding that most grades II and III gliomas harbor isocitrate dehydrogenase (IDH)
mutations conveying a relatively favorable and fairly similar prognosis in both tumor grades …
mutations conveying a relatively favorable and fairly similar prognosis in both tumor grades …
Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy
G Ceccon, P Lohmann, G Stoffels, N Judov… - Neuro …, 2017 - academic.oup.com
Background The aim of this study was to investigate the potential of dynamic O-(2-[18F]
fluoroethyl)-L-tyrosine (18F-FET) PET for differentiating local recurrent brain metastasis from …
fluoroethyl)-L-tyrosine (18F-FET) PET for differentiating local recurrent brain metastasis from …